Open Access<p>Tedizolid phosphate for the treatment of acute bacterial skin and skin-structure infections: an evidence-based review of its place in therapy</p>
Author(s) -
Matteo Bassetti,
Nadia Castaldo,
Alessia Carnelutti,
Maddalena Peghin,
Daniele Roberto Giacobbe
Publication year - 2019
Publication title -
core evidence
Language(s) - English
Resource type - Journals
eISSN - 1555-175X
pISSN - 1555-1741
DOI - 10.2147/ce.s187499
Subject(s) - medicine , linezolid , tolerability , clinical trial , adverse effect , staphylococcus aureus , vancomycin , biology , bacteria , genetics
Tedizolid phosphate is an oxazolidinone approved for the treatment of acute bacterial skin and skin-structure infections (ABSSSIs) and active against methicillin-resistant Staphylococcus aureus .